Biotinylated Human Claudin-6 / CLDN6 Full Length Protein (VLP)

Related Products: Cell line CHEK-ATP138, Streptavidin Series Products
1/5
+2 View all
製品番号/仕様
価格
Availability
数量
CL6-H82P3-20ug
$620.00
In Stock - Delivery in 1-2 business days
CL6-H82P3-100ug
$1,235.00
In Stock - Delivery in 1-2 business days
CL6-H82P3-500ug (250ug X 2)
$4,305.00
In Stock - Delivery in 1-2 business days
CL6-H82P3
製品金額 :
$ 0
推奨新製品 Request Quote
Contact Us
Contact Us
製品金額:
$ 0
  • 製品詳細
  • データ表示
  • Reviews & Citations
  • Important Statement
  • Resources
Application
  • Immunization
  • Cell based assay (FACS or functional assay)
  • Screening (ELISA)
Synonyms

Claudin-6, CLDN6

Source

Biotinylated Human Claudin-6 Full Length Protein (VLP) (CL6-H82P3) is expressed from human 293 cells (HEK293). It contains AA Met 1 - Val 220 (Accession # P56747).

Predicted N-terminus: Met 1

Molecular Characterization

*The isotype control of empty/mock VLP (Cat. No. VLP-N82P3) is sold separately and not included in protein, you can follow the link for product information.

Structure

Virus-like particles (VLPs) are protein particles that mimic the shape of viruses but lack a viral genome, and incorporating transmembrane proteins on the external surface.

Synthesis Process

Envelope virus-like particles (eVLPs) are produced by co-expressing target membrane proteins with viral structural proteins in mammalian cells, enabling native embedding of membrane proteins into the lipid bilayer during VLP budding. This approach preserves authentic conformation, post-translational modifications, and orientation, while creating a completely detergent-free environment with repetitive multivalent display and strong immunogenicity making them ideal for immunization, binding assays in antibody discovery and screening (ELISA), and cell-based assays such as FACS, etc.

Labeling

The VLP is biotinylated with proprietary technology.

Protein Ratio

Passed as determined by the HABA assay / binding ELISA.

Formulation

The VLPs are highly immunogenic, so the immunization strategy should be optimized (antigen dose, regimen and adjuvant).

Supplied as 0.2 μm filtered solution in PBS, Arginine, pH7.4 with trehalose as protectant.

Contact us for customized product form or formulation.

Shipping and Storage

This product is supplied and shipped on dry ice.

Please avoid repeated freeze-thaw cycles.

This product is stable after storage at:
  • The product MUST be stored at -70°C or lower upon receipt;
  • -70°C for 12 months under sterile conditions.

バックグランド

An oncofetal tight junction protein absent in normal adult tissues but aberrantly expressed in ovarian, endometrial, and testicular cancers. Its strict cancer specificity and extracellular accessibility make it an ideal candidate for CAR-T cell therapy and bispecific antibody development.